Our cardiovascular teams use the newest technologies to help our patients recover faster, with fewer complications.

WE are revolutionizing vascular care with another first at OhioHealth

OhioHealth offers the most comprehensive vascular care in the region. Now, OhioHealth’s peripheral vascular physicians at Riverside Methodist Hospital are the first in the nation to treat patients with a new FDA-approved drug-coated stent - the first stent ever used outside the heart.  The success of the Zilver PTX stent, combined with Grant Medical Center’s treatment of more vascular surgery patients than any other central Ohio hospital, makes it easy to see why WE are at the forefront in treating peripheral artery disease.

With the development of the new drug-eluting stent, treatment of PAD in the United States is expected to undergo a revolution akin to the use of drug elution in treating coronary artery disease. In the clinical trial, eight in ten patients treated with the new stent still had open arteries after one year, compared to three in ten treated with angioplasty alone. In addition, patients who received a bare metal stent required more than twice as many repeat procedures to reopen the artery as patients who received the new stent. It’s a revolution in peripheral vascular care and it’s only available at OhioHealth now.

It’s important to recognize the symptoms of peripheral artery disease. One in every 20 Americans over the age of 50 are affected. Some signs include:

  • Pain, numbness, aching, or heaviness in the leg muscles when walking or climbing stairs
  • Cramping in the affected leg(s) and in the buttocks, thighs, calves, and feet when walking or climbing stairs.
  • Weak or absent pulses in the legs or feet

For more information on other symptoms, treatment options and care, go to Peripheral artery disease (PAD).

We're unblocking heart arteries from the same place WE take your pulse

OhioHealth cardiologists are using transradial access- getting to the heart arteries through the wrist. The majority of catheterizations done in the U.S. are performed through the femoral artery (in the groin), which requires patients be confined to a hospital bed for hours after the procedure to ensure excess bleeding does not occur.

Transradial access carries a lower risk of bleeding, less chance of infection and a shorter recovery time, patients can often be up and walking just minutes after the procedure, often avoiding an overnight stay. 

OhioHealth patients have more access to this option than anywhere else in town because our expert physicians are performing this procedure at all of our cath labs at Riverside Methodist, Grant Medical Center, Doctors Hospital, Grady Memorial and Marion General. Transradial access is an advanced treatment option many patients can have but not all qualify for it. Talk to your doctor to find out if this procedure is an option for you.

Your partner in structural heart disease and your leader in advanced treatments

OhioHealth's Riverside Methodist Hospital provides innovative cardiovascular medicine incorporating multi-disciplinary physician collaboration, groundbreaking treatments and research to patients through the OhioHealth Structural Heart Disease Patient Evaluation & Research Center. 

OhioHealth is recognized as a leader in revolutionary treatment of stroke, peripheral vascular disease and cardiovascular conditions such as heart valve disease and coronary artery disease.

First in the central Ohio region to offer two, non-surgical alternatives in treating severe aortic stenosis

As the central Ohio leader in structural heart disease treatments, we offer less invasive options for patients with severe aortic stenosis: 

  • The Edwards SAPIEN Transcatheter Heart Valve is an immediate treatment option at OhioHealth's Riverside Methodist Hospital.  This valve is a new FDA-approved procedure used for patients deemed inoperable for open-heart surgery.  This new, transcatheter procedure is a non-invasive way to replace diseased native heart valve for aortic stenosis patients.
  • Read more about our second non-surgical treatment option, Medtronic CoreValve U.S. Pivotal Trial coordinated through the OhioHealth Research Institute.

Advanced Technology for Atrial Fibrillation

We provide heart patients suffering from atrial fibrillation the option of cryo ablation, an advanced technology in the field of catheter ablation.

Catheter ablation is a minimally invasive procedure in which a flexible thin tube is threaded through the blood vessels to your heart to stop abnormal electrical signals occuring in the heart tissue.

Cryo ablation uses a cooling material that is delivered within the catheter to cool the catheter tip. This freezes the disruptive tissue sending the abnormal electrical signals, so they can no longer interfere with the heart's normal rhythm.

Advantages of this advanced technology include complete isolation of the treatment area and a decrease in the time. What once took four to six hours now takes two to three. 

A New Approach for Angioplasty: Radial Access PCI

OhioHealth interventional cardiologists are using transradial access for angioplasty, also known as PCI or percutaneous coronary intervention.

Angioplasty is used to open narrowed or blocked coronary arteries. During the procedure, cardiac interventionists make a small incision through which they thread a catheter to access the blockage in the heart. By using the radial artery in the wrist instead of the femoral artery in the groin, patients experiences faster recovery rates and fewer complications.

PFO Closure: Preventing Future Strokes

Riverside Methodist Hospital and Grant Medical Center cardiologists treat patent foramen ovale (PFO) and paradoxical embolization (blood clots) with an innovative non-surgical closure procedure to help prevent future strokes.

The procedure provides a low-risk alternative to open-heart surgery, requiring a small incision and an overnight stay. Patients eligible for this type of treatment include patients who have had a stroke and want to eliminate or cannot tolerate lifelong anticoagulation (blood-thinning) medications. The procedure also helps restore higher energy levels and reduces the risk of heart failure in patients who experience fatigue-related symptoms.

The Endovascular Hybrid Operating Room

Riverside Methodist's endovascular hybrid OR uses technologies that integrate diagnosis and treatment and allow medical specialists to collaborate on patient care, paving the way for:

  • Fewer surgeries
  • Safer procedures
  • Shorter hospital stays
  • Faster recoveries
  • Better outcomes

In the region's most advanced surgical suite of its kind, nearly all the medical devices and other equipment are ceiling mounted for better ergonomics and faster set-up. All the technology is controlled electronically by the surgical team and enables multiple specialists to collaborate on treating each patient's unique medical needs.